Physician profile
Carole Jackson
NPI 1427020882
$4,056.51
in general payments reported to CMS, 2019-2025
38 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $466 · 2021: $1,062 · 2022: $1,132 · 2023: $827 · 2024: $69.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $702 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $702.15 |
| Education | $193.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $672.58 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $363.74 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $310.54 | 2019-2023 | |
| Pfizer INC. | $285.39 | 2019-2022 | |
| Astellas Pharma US INC | $273.47 | 2023-2024 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $221.75 | 2019-2023 | Slynd |
| Evofem Biosciences, INC. | $201.68 | 2021-2023 | Phexxi |
| Allergan, INC. | $198.84 | 2019-2022 | |
| Avion Pharmaceuticals | $166.13 | 2020-2022 | |
| Mylan Pharmaceuticals INC. | $129.98 | 2020-2022 | |
| Therapeuticsmd, INC. | $128.75 | 2019-2022 | |
| Organon LLC | $127.96 | 2021-2024 | Nexplanon |
| Medtronic, INC. | $120.14 | 2022-2023 | Interstim |
| Merck Sharp & Dohme LLC | $92.34 | 2019-2022 | |
| Davol INC. | $83.38 | 2020-2023 | Arista Ah Flexitip |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $71.59 | 2019 | |
| Amgen INC. | $69.91 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $62.88 | 2019 | |
| Minerva Surgical, INC | $57.18 | 2021-2022 | |
| Hologic Sales and Service, LLC | $45.52 | 2019-2021 | |
| Myovant Sciences INC. | $37.95 | 2022 | |
| Urovant Sciences INC | $33.37 | 2022 | |
| Eisai INC. | $30.88 | 2020 | |
| Smith+Nephew, INC. | $30.46 | 2021-2022 | |
| Lilly USA, LLC | $29.33 | 2022-2023 | Reyvow, Emgality |
| Meditrina | $21.96 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $21.56 | 2023 | Exparel |
| Radius Health, INC. | $19.00 | 2022 | |
| Medline Industries LP | $17.91 | 2022 | |
| Convatec INC. | $17.64 | 2020 | |
| Ethicon US, LLC | $16.65 | 2020 | |
| Sumitomo Pharma America, INC. | $16.07 | 2023 | Myfembree |
| Baudax Bio INC. | $15.89 | 2020 | |
| Aspira Women'S Health INC | $13.80 | 2022 | |
| Sage Therapeutics, LLC | $13.72 | 2020 | |
| Idorsia Pharmaceuticals US INC | $13.48 | 2022 | |
| Agile Therapeutics, INC. | $11.83 | 2021 | |
| Lupin INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carole Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.